| AI | artificial intelligence |
| AID | activation-induced cytidine deaminase |
| AKT | protein kinase B |
| APOBEC | apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like |
| AR | androgen receptor |
| CAF | cancer-associated fibroblast |
| COSMIC | Catalogue of Somatic Mutations in Cancer |
| CTLA-4 | cytotoxic T-lymphocyte-associated protein 4 |
| dMMR | mismatch repair-deficient |
| HPV | human papillomavirus |
| HRD | homologous recombination deficiency |
| IHC | immunohistochemistry |
| MMR | mismatch repair |
| MSI | microsatellite instability |
| MSS | microsatellite stable |
| MTS | Muir–Torre syndrome |
| mTOR | mechanistic target of rapamycin |
| NGS | next-generation sequencing |
| NK | natural killer |
| PD-1 | programmed cell death protein 1 |
| PD-L1 | programmed death-ligand 1 |
| PI3K | phosphatidylinositol 3-kinase |
| SC | sebaceous carcinoma |
| SC-E | extraocular sebaceous carcinoma |
| SC-O | ocular/periocular sebaceous carcinoma |
| SEER | Surveillance, Epidemiology, and End Results |
| TMB | tumor mutational burden |
| TME | tumor microenvironment |
| Treg | regulatory T cell |
| UV | ultraviolet |
| WES | whole-exome sequencing |
| WGS | whole-genome sequencing |
| WTS | whole-transcriptome sequencing |
| YAP | Yes-associated protein |